For a patient with hearing aids, the challenge often begins after the device is fitted. Background noise, crowded rooms, and the brain's own lag in processing new auditory signals can make the expensive hardware feel ineffective. Neurotone AI is building its business on that post-fitting gap, selling digital rehabilitation tools directly to audiologists and hearing care professionals [Neurotone support, 2024].
The company's flagship product, LACE AI Pro, is the evolution of a program with a long clinical tail. Its predecessor, LACE (Listening and Communication Enhancement), is supported by more than 80 peer-reviewed publications and over a decade of clinical trials [The Audiology Place, 2026]. In October 2024, Neurotone AI launched Tinnitus Pro, a companion application that integrates sound therapy, cognitive behavioral therapy (CBT) principles, and clinician monitoring tools [PRWeb, Oct 2024]. The development involved notable clinical advisors including Dr. Robert Sweetow and Dr. Nancy Tye-Murray [The Hearing Review, 2024].
The bet on the clinician's desktop
Neurotone AI's strategy bypasses the direct-to-consumer health app frenzy. Its customers are exclusively licensed hearing professionals. The company sells lifetime licenses to these clinics, with Tinnitus Pro offered at a $499 one-time fee per patient [Perplexity Sonar, 2024]. This model contrasts with subscription SaaS norms, betting on simplicity and permanence. For a clinic, the product becomes a fixed-cost tool they can prescribe repeatedly.
Building on a foundation of clinical credibility
The leadership and advisory structure is designed to reinforce this clinical focus. Co-founder and CEO Rick Carlson provides the operational helm, while co-founder and COO Dr. Miles Aaron adds a clinical doctorate [PRWeb, Oct 2024] [Hearing Health & Technology Matters, 2025]. The involvement of Dr. Nancy Tye-Murray as an affiliate signals an intent to stay grounded in peer-reviewed science [LinkedIn, 2026]. The company's backers include a mix of regional and thematic funds like the Charlotte Angel Fund and Temprano Techvestors [Crunchbase, 2024].
| Role | Name | Note |
|---|---|---|
| Co-Founder & CEO | Rick Carlson | CEO since March 2022 [Clay.earth / LinkedIn, 2026]. |
| Co-Founder & COO | Dr. Miles Aaron | Holds a clinical doctorate [Dr. Cliff Show YouTube, 2026]. |
| Clinical Affiliate | Dr. Nancy Tye-Murray, PhD | Published researcher in auditory training [LinkedIn, 2026]. |
| Clinical Advisor | Dr. Robert Sweetow | Contributed to Tinnitus Pro development [The Hearing Review, 2024]. |
The competitive and commercial landscape
Operating in a specialized corridor of digital health brings distinct advantages and challenges. The primary advantage is a clear, professional buyer with a defined need: improving patient outcomes and reducing costly hearing aid returns. The regulatory context is also clearer, as the tools are sold as aids to a licensed practitioner. However, the market is finite and sales cycles can be long. Furthermore, the lifetime license model places the entire burden of growth on new customer acquisition.
Neurotone AI is attempting to codify and scale the rehabilitative step, placing a digital therapist in the patient's pocket, but always with the clinician kept in the loop.